(Q61889836)
Statements
Treatment-by-histology interaction analyses in three phase III trials show superiority of pemetrexed in nonsquamous non-small cell lung cancer (English)
Giorgio Scagliotti
Thomas Brodowicz
Christoph Zielinski
Johan Vansteenkiste
Christian Manegold
Lorinda Simms
Katherine Sugarman
Frances A Shepherd
1 January 2011